CLINICAL_TRIALS
trial_result
· 2013-07-31
Clinical Trial Update: Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma [Phase 3]
Summary
This Phase 3 trial evaluated the efficacy and safety of two doses of tiotropium delivered by Respimat in adults with mild persistent asthma. Results were posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2013-07-31